27 March 2014 - Deborah Wilkes
Archived
The US OTC drug review is in a "slow death spiral" because the Center for Drug Evaluation and Research (CDER) has decided "OTC drugs are unimportant and trivial", according to Peter Barton Hutt, former chief counsel at the US Food and Drug Administration (FDA).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.